ACTIVE

OncoDNA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-3,8 M €

+26.3% YoY

Gross margin

2,1 M €

+72.3% YoY

Equity

-256,6 k €

-134.0% YoY

Workforce

20,6 ETP

-6.4% YoY

What does OncoDNA do?

OncoDNA is a Public limited company incorporated in 2012. Its main activity is: Other human health activities. Its registered office is in Charleroi. It employs on average 20,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0501.631.837

Incorporation

29/11/2012

Legal form

Public limited company

Registered office

Rue Louis Breguet 1
6041 Charleroi · WallonieSee on map

Contributed capital

4 328 101,08 €

Latest accounts

31/12/2025

Average workforce

20,6 ETP

Activities (NACE)

86901Other human health activities· main 86910Other human health activities

Joint committees (2)

330
330.04

Contacts

2 public details availableLog in to view

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	2,1 M €	+72.3%	1,2 M €	+56.9%	769,5 k €	+275%	-439,2 k €	-370%	162,8 k €	+128%	-578,9 k €	-135%	1,7 M €	+69.9%	973,8 k €	+4514%	21,1 k €	+107%	-297,8 k €	-197%	307,4 k €	+505%	-75,8 k €	-374%	27,7 k €
EBITDA	-592,1 k €	+67.9%	-1,8 M €	+44.2%	-3,3 M €	+24.9%	-4,4 M €	-11.1%	-4 M €	+13.2%	-4,6 M €	-218%	-1,4 M €	+47.2%	-2,7 M €	+14.7%	-3,2 M €	-118%	-1,5 M €	-395%	-295,8 k €	+31.4%	-431 k €	-290%	-110,6 k €
Operating result	-2,1 M €	+40.3%	-3,5 M €	+30.5%	-5,1 M €	+20.2%	-6,4 M €	-53.1%	-4,2 M €	+17.7%	-5,1 M €	-108%	-2,4 M €	+25.8%	-3,3 M €	+12.9%	-3,8 M €	-91.3%	-2 M €	-321%	-469,6 k €	+20.2%	-588,3 k €	-195%	-199,2 k €
Net result	-3,8 M €	+26.3%	-5,1 M €	+50.4%	-10,4 M €	-68.8%	-6,1 M €	-16.8%	-5,3 M €	+2.9%	-5,4 M €	-72.6%	-3,1 M €	+4.2%	-3,3 M €	+12.5%	-3,7 M €	-87.5%	-2 M €	-376%	-419,6 k €	+23.1%	-545,3 k €	-416%	-105,6 k €
Balance sheet
Equity	-256,6 k €	-134%	755,7 k €	-87.0%	5,8 M €	-41.6%	10 M €	-39.8%	16,6 M €	+4.3%	15,9 M €	+252%	4,5 M €	+14644%	30,7 k €	-96.6%	903,9 k €	-59.9%	2,3 M €	+294%	572,6 k €	+9311%	6,1 k €	-98.2%	343,5 k €
Total assets	5,3 M €	-53.7%	11,4 M €	-14.9%	13,4 M €	-32.8%	19,9 M €	-18.2%	24,3 M €	-14.0%	28,3 M €	+178%	10,2 M €	+35.8%	7,5 M €	+38.5%	5,4 M €	+3.9%	5,2 M €	+106%	2,5 M €	+58.4%	1,6 M €	+138%	671,2 k €
Cash	520,6 k €	-51.0%	1,1 M €	-29.1%	1,5 M €	-29.2%	2,1 M €	-62.8%	5,7 M €	-39.8%	9,5 M €	+282%	2,5 M €	+185%	869 k €	+7.9%	805,4 k €	-63.6%	2,2 M €	+219%	693,2 k €	+262%	191,7 k €	+137%	80,8 k €
Debts	5,4 M €	-47.1%	10,3 M €	+39.8%	7,4 M €	-25.3%	9,9 M €	+28.6%	7,7 M €	-36.9%	12,1 M €	+122%	5,5 M €	-25.8%	7,4 M €	+72.6%	4,3 M €	+50.5%	2,8 M €	+45.6%	2 M €	+41.9%	1,4 M €	+1184%	107,1 k €
Other
Workforce	20,6 ETP	-6.4%	22,0 ETP	-28.3%	30,7 ETP	-2.5%	31,5 ETP	-6.8%	33,8 ETP	-9.9%	37,5 ETP	+20.2%	31,2 ETP	-18.1%	38,1 ETP	-4.7%	40,0 ETP	+122%	18,0 ETP	+73.1%	10,4 ETP	+67.7%	6,2 ETP	+210%	2,0 ETP

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 62 ended

Active mandates

An Herremans

Director · since 17 mai 2023 · until 17 juin 2026

Active

Charles-André Brouwers

Director · since 17 mai 2023 · until 17 juin 2026

Active

François Blondel

Director · since 17 mai 2023 · until 17 juin 2026

Active

GELDHOF ENTERPRISES

Director · since 17 mai 2023 · until 17 juin 2026 · 0474.301.888

Represented by Guy Geldhof

Active

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 17 mai 2023 · until 17 juin 2026 · 0253.445.063

Represented by François Fontaine

Active

Ended mandates

An Herremans

Director · since 17 mai 2023 · until 02 juin 2026

Ended

Charles-André Brouwers

Director · since 17 mai 2023 · until 02 juin 2026

Ended

François Blondel

Director · since 17 mai 2023 · until 02 juin 2026

Ended

GELDHOF ENTERPRISES

Director · since 17 mai 2023 · until 02 juin 2026 · 0474.301.888

Represented by Guy Geldhof

Ended

At this address

Other companies at this address

Company	CBE no.
OncoRNA● Active	0805.162.158

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2026	30/07/2025	23/07/2024	27/07/2023	31/10/2022	21/06/2021
General meeting	17/06/2026	18/07/2025	18/07/2024	20/06/2023	02/06/2022	02/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

15 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	17/06/2026	14/07/2026	French	PDF
Abridged model	31/12/2024	18/07/2025	30/07/2025	French	PDF
Abridged model	31/12/2023	18/07/2024	23/07/2024	French	PDF
Abridged modelCorrection	31/12/2022	20/06/2023	27/07/2023	French	PDF
Abridged model	31/12/2022	01/06/2023	05/07/2023	French	PDF
Abridged modelCorrection	31/12/2021	02/06/2022	31/10/2022	French	PDF
Abridged model	31/12/2021	02/06/2022	22/06/2022	French	PDF
Abridged model	31/12/2020	02/06/2021	21/06/2021	French	PDF
Abridged model	31/12/2019	03/06/2020	02/07/2020	French	PDF
Abridged model	31/12/2018	18/06/2019	05/07/2019	French	PDF
Abridged model	31/12/2017	07/06/2018	21/06/2018	French	PDF
Abridged model	31/12/2016	01/06/2017	06/06/2017	French	PDF
Abridged model	31/12/2015	14/06/2016	11/07/2016	French	PDF
Abridged model	31/12/2014	04/06/2015	23/06/2015	French	PDF
Abridged model	31/12/2013	10/06/2014	27/06/2014	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 62 ended

Active mandates

An Herremans

Director · since 17 mai 2023 · until 17 juin 2026

Active

Charles-André Brouwers

Director · since 17 mai 2023 · until 17 juin 2026

Active

François Blondel

Director · since 17 mai 2023 · until 17 juin 2026

Active

GELDHOF ENTERPRISES

Director · since 17 mai 2023 · until 17 juin 2026 · 0474.301.888

Represented by Guy Geldhof

Active

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 17 mai 2023 · until 17 juin 2026 · 0253.445.063

Represented by François Fontaine

Active

Ended mandates

An Herremans

Director · since 17 mai 2023 · until 02 juin 2026

Ended

Charles-André Brouwers

Director · since 17 mai 2023 · until 02 juin 2026

Ended

François Blondel

Director · since 17 mai 2023 · until 02 juin 2026

Ended

GELDHOF ENTERPRISES

Director · since 17 mai 2023 · until 02 juin 2026 · 0474.301.888

Represented by Guy Geldhof

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates17/06/2026
DEMISSIONS, NOMINATIONS
PDF
Capital / shares04/06/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Capital / shares18/04/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates20/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates20/06/2024
DEMISSIONS, NOMINATIONS
PDF
Capital / shares26/06/2023
CAPITAL, ACTIONS
PDF
Mandates16/06/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates28/07/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-3,8 M €↑
2024
Annual accounts 2024-5,1 M €↑
2023
Annual accounts 2023-10,4 M €↓
2022
Annual accounts 2022-6,1 M €↓
2021
Annual accounts 2021-5,3 M €↑
2020
Annual accounts 2020-5,4 M €↓
2019
Annual accounts 2019-3,1 M €↑
2018
Annual accounts 2018-3,3 M €↑
2017
Annual accounts 2017-3,7 M €↓
2016
Annual accounts 2016-2 M €↓
2015
Annual accounts 2015-419,6 k €↑
2014
Annual accounts 2014-545,3 k €↓
2013
Annual accounts 2013-105,6 k €
29/11/2012
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

OncoDNA

Overview

What does OncoDNA do?

Trend over 13 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline